Showing results (41-50 of 52) with videos related to
Sort By:
Pageof 6
Experimental Eye Research|March 14, 2017
Retinal accumulation of zeaxanthin, lutein, and β-carotene in mice deficient in carotenoid cleavage enzymesBinxing Li, Preejith P Vachali, Zhengqing Shen, et al.Journal of Cardiovascular Computed Tomography|October 12, 2024
Temporal trend and regional disparity in the investigations for stable chest pain in Europe: An insight from the PIONEER IV trialTsung-Ying Tsai, Patrick W Serruys, Joanna Wykrzykowska, et al.Phytomedicine : International Journal of Phytotherapy and Phytopharmacology|June 29, 2012
Lipid-lowering effect of berberine in human subjects and ratsYueshan Hu, Erik A Ehli, Julie Kittelsrud, et al.Journal of Cutaneous Pathology|June 27, 2018
Suprabasal acantholytic dermatologic toxicities associated checkpoint inhibitor therapy: A spectrum of immune reactions from paraneoplastic pemphigus-like to Grover-like lesionsWei-Shen Chen, Michael T Tetzlaff, Hafeez Diwan, et al.Journal of Cutaneous Pathology|January 11, 2024
Nectin-4 expression in a subset of cutaneous adnexal carcinomas: A potential target for therapy with enfortumab vedotinWoo Cheal Cho, Rayan Saade, Priyadharsini Nagarajan, et al.The Journal of Pediatrics|July 1, 2019
Lack of Equipoise in the PDA-TOLERATE Trial: A Comparison of Eligible Infants Enrolled in the Trial and Those Treated Outside the TrialMelissa Liebowitz, Anup Katheria, Jason Sauberan, et al.The Journal of Pediatrics|September 26, 2020
Prolonged Tracheal Intubation and the Association Between Patent Ductus Arteriosus and Bronchopulmonary Dysplasia: A Secondary Analysis of the PDA-TOLERATE trialRonald I Clyman, Joseph Kaempf, Melissa Liebowitz, et al.The Journal of Pediatrics|October 21, 2018
PDA-TOLERATE Trial: An Exploratory Randomized Controlled Trial of Treatment of Moderate-to-Large Patent Ductus Arteriosus at 1 Week of AgeRonald I Clyman, Melissa Liebowitz, Joseph Kaempf, et al.Journal of Perinatology : Official Journal of the California Perinatal Association|March 10, 2019
Comparative effectiveness of drugs used to constrict the patent ductus arteriosus: a secondary analysis of the PDA-TOLERATE trial (NCT01958320)Melissa Liebowitz, Joseph Kaempf, Omer Erdeve, et al.Journal of the National Comprehensive Cancer Network : JNCCN|June 15, 2026
Melanoma: Cutaneous, Version 2.2026, NCCN Clinical Practice Guidelines In OncologySusan M Swetter, Douglas Johnson, Mark R Albertini, et al.Pageof 6